Representation of Check-Cap Ltd. in a warrant exercise transaction with several existing institutional investors who were holders of certain outstanding warrants to purchase the Company’s ordinary shares issued in prior registered direct offerings. In connection with the transaction, the holders exercised in cash their prior warrants, at a reduced exercise price of $0.6 per share. […]
Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of millions of dollars. Luminera Derm is an R&D company as well as a manufacturer […]
Representation of Flash Networks Ltd. in a reverse triangular merger transaction and the purchase of 100% of its share capital by the Volaris Group, a Canadian operating group of Constellation Software Inc., a diversified software company, publicly traded and based in Canada. Press: see here
Representation of Kitov Pharma Ltd. in a US$35M registered direct offering of shares represented by American Depositary Shares (ADSs) and warrants to purchase ADSs. H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering. Kitov Pharma Ltd. (NASDAQ/TASE: KTOV) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune […]
FBC and DLA Piper represented AngioDynamics Inc., in an acquisition of Eximo Medical Ltd., an Israeli company. The transaction included extensive and sensitive negotiations of the terms and conditions of the acquisition from the various shareholders of Eximo Medical Ltd. and included the purchase of the company’s shares and treatment of the company’s options and […]
FBC represented OrbiMed in its $5,325,000 investment in MobileODT Ltd. as part of a Series B Round of approximately $6,825,000 investment, in addition to conversion of SAFEs (“simple agreement for future equity”) in the amount of $3,905,223. The transaction included complex questions with regard to the applicability of the Israeli Securities Law and IP. MobileODT […]
עו”ד עמית פינס מונה ככונס נכסים על בניין פישמן רשתות, נכס בבעלות חברת תרזליט מקבוצת חברות של אליעזר פישמן אשר נקלעו למצב של חדלות פירעון. במסגרת הליכי הכינוס נמכר הנכס לחברת ריט 1, בסך של 119 מיליון ש”ח. בעיתונות, לחצו כאן.
FBC represented Applied Immune Technologies Ltd. (“AIT”), a drug development company specializing in therapeutic applications for cancer and other autoimmune diseases, owned by Technion Research and Development Foundation Ltd., Technion Investment Opportunities Fund, OrbiMed Israel Partners Limited Partnership, Novartis Bioventures Ltd., Pontifax funds and others, in a complex merger transaction for the purchase and sale […]
FBC advises Rainbow Medical, a leading R&D and operational investment company, specializing in seeding and incubating medical device startups and developing breakthrough medical technologies, in raising $25 million from investors in China and opened a China office to promote strategic collaborations. “We opened the office in Shanghai to capitalize on China’s fast-growing market for our […]
FBC advises Orbimed in an investment in Atox Bio, a clinical stage company which develops novel immune-modulators for severe infections.
FBC advises Orbimed in an investment in Nucleix, which develops a test for early detection of bladder cancer.
FBC advises Orbimed in an investment in Keystone Heart, which develops and manufactures embolic cerebral protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures.
FBC advises the OrbiMed Fund, in a $6M private placement transaction in RedHill Biopharma, a public company dually listed on the NASDAQ and TASE.
FBC advises Perrigo, a NYSE and TASE-traded company, in the Israeli aspects relating to the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland.
FBC represents Kamada in Israeli aspects related to its $60M Nasdaq IPO